{
  "abstract": "Recent advances in nuclear medicine are reshaping the evaluation of cardiac amyloidosis, as highlighted by the recent collection published in EJNMMI (collection link: https://link.springer.com/collections/igfdhcddjg). This commentary summarizes key insights from these studies, emphasizing the evolving shift from conventional diagnostic imaging toward a more integrated and comprehensive approach. Emerging developments include novel amyloid PET tracers, improved diagnostic accuracy with SPECT/CT, multimodality imaging strategies, and enhanced assessment of systemic disease burden extending beyond the left ventricle. There is also growing interest in longitudinal monitoring, pre-symptomatic detection, and the role of artificial intelligence. Together, these advances position nuclear medicine as an essential tool for disease characterization, risk stratification, and treatment assessment.",
  "abstract_shown": true,
  "affiliations": [
    "Division of Nuclear Medicine, Department of Radiology, SSM Health Saint Louis University Hospital, St. Louis, MO, USA. mehdi.zirak@gmail.com.",
    "Division of Nuclear Medicine, Department of Radiology, SSM Health Saint Louis University Hospital, St. Louis, MO, USA."
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 2,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Mahdi Zirakchian Zadeh"
    },
    {
      "affs": [
        1
      ],
      "name": "Medhat M Osman"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/0ryv6k2f799ea.bib",
  "cited_by": 0,
  "doi": "10.1186/s41824-026-00326-3",
  "fulltext_url": "https://europepmc.org/articles/PMC13677663",
  "id": "0ryv6k2f799ea",
  "issns": [
    "3005-074X"
  ],
  "landing_url": "https://europepmc.org/article/MED/42894083",
  "language": "eng",
  "licence": "CC-BY-NC-ND",
  "licence_label": "CC BY-NC-ND",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by-nc-nd/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "lcc",
      "R895-920"
    ],
    [
      "openalex",
      "1312|Amyloidosis: Diagnosis, Treatment, Outcomes"
    ]
  ],
  "openalex": "W7222877339",
  "pdf_url": "https://europepmc.org/articles/PMC13677663?pdf=render",
  "pmcid": "PMC13677663",
  "pmid": "42894083",
  "published": "2026-10-19",
  "publisher": "Springer",
  "ris": "https://research.draconitic.com/paper/0ryv6k2f799ea.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:19:33Z",
      "native_id": "MED:42894083",
      "source": "europepmc",
      "url": "https://europepmc.org/article/MED/42894083"
    },
    {
      "first_seen": "2026-10-30T13:45:34Z",
      "native_id": "617461392f8043399d62650566db9a95",
      "source": "doaj",
      "url": "https://doi.org/10.1186/s41824-026-00326-3"
    }
  ],
  "subjects": [
    {
      "field": "biochemistry",
      "origin": "openalex:1312|Amyloidosis: Diagnosis, Treatment, Outcomes",
      "subfield": "molecular-biology"
    }
  ],
  "title": "Expanding role of nuclear medicine in cardiac amyloidosis: insights from the EJNMMI collection.",
  "title_text": "Expanding role of nuclear medicine in cardiac amyloidosis: insights from the EJNMMI collection.",
  "type": "peer-reviewed",
  "updated_at": "2026-10-30T13:45:34Z",
  "url": "https://research.draconitic.com/paper/0ryv6k2f799ea",
  "venue": "EJNMMI reports",
  "versions": []
}